Orphan Drug Designation Sends Shares of this Dual-Listed Life Science Therapy Company Soaring
15 Fevereiro 2024 - 3:15PM
AllPennyStocks.com
Orphan drug designation, or ODD, is valuable on both a
humanitarian and a profitability basis. And this company is seeing
shares rally following news that it was granted the designation for
the...
To read the full story on AllPennyStocks.com, click
here.
Cardiol Therapeutics (NASDAQ:CRDL)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
Cardiol Therapeutics (NASDAQ:CRDL)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025